Rx Clv2 B
Vendor:
First CVE: Nov 17, 2017 · Active for 8 years
1
Total CVEs
Bottom 1%
1.0
Avg CVEs / Year
Bottom 1%
4.6
Avg CVSS
Higher Avg CVSS than 5% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Rx Clv2 B over time
Volume of CVEsAvg CVSS Base Score
First CVE
Nov 17, 2017
8 years ago
Most Recent CVE
Nov 17, 2017
3,171 days ago
CVE Severity & Scoring
Rx Clv2 B1 CVEs
100%
All CVEs352,231 CVEs
45%
40%
11%
Medium
Attack Vector
Local0 (0.0%)
Network0 (0.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network1 (100.0%)
Attack Complexity
Low1 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None0 (0.0%)
Unknown0 (0.0%)
Required1 (100.0%)
Privileges Required
Low0 (0.0%)
High0 (0.0%)
None1 (100.0%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2017-10890MEDIUM Session management issue in RX-V200 firmware versions prior to 09.87.17.09, RX-V100 firmware versions prior to 03.29.17.09, RX-CLV1-P firmware versions prior to 79.17.17.09, RX-CLV | Nov 17, 2017 | 4.6 | 14 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (1 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (1 CVEs).
Media Mentions
Signals from CVEs in this product scope (1 CVEs).
Top CNAs Publishing CVEs For Rx Clv2 B
Top CWEs
Versions
No cataloged versions.